Clarus Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-656
Closed -$208K 122
2024
Q3
$208K Sell
656
-68
-9% -$22.2K 0.11% 129
2024
Q2
$233K Buy
+724
New +$213K 0.12% 113
2024
Q1
Sell
-695
Closed -$212K 132
2023
Q4
$212K Buy
+695
New +$189K 0.13% 111
2021
Q2
Sell
-2,304
Closed -$574K 102
2021
Q1
$574K Hold
2,304
0.36% 56
2020
Q4
$547K Hold
2,304
0.36% 51
2020
Q3
$582K Hold
2,304
0.45% 48
2020
Q2
$583K Hold
2,304
0.49% 41
2020
Q1
$473K Hold
2,304
0.47% 63
2019
Q4
$550K Hold
2,304
0.36% 74
2019
Q3
$446K Buy
2,304
+2,180
+1,758% +$418K 0.33% 72
2019
Q2
$23K Buy
124
+1
+0.8% +$179 0.02% 349
2019
Q1
$23K Sell
123
-16
-12% -$3.06K 0.02% 394
2018
Q4
$27K Buy
139
+1
+0.7% +$195 0.04% 352
2018
Q3
$29K Buy
138
+13
+10% +$2.56K 0.02% 377
2018
Q2
$21K Buy
+125
New +$22.1K 0.02% 418

Other funds holding AMGN

Clarus Wealth Advisors's AMGN Position: Q4 2024 in Review

Clarus Wealth Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 656 shares — an estimated $208K sold.

Clarus Wealth Advisors first reported a position in AMGN in Q2 2018 and held it in 15 quarters. The position peaked at $583K in Q2 2020. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Clarus Wealth Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Clarus Wealth Advisors sold 656 Amgen shares in Q4 2024, an estimated $208K.
  • Clarus Wealth Advisors first reported a position in Amgen in Q2 2018 and held it in 15 quarters.
  • Clarus Wealth Advisors's Amgen position peaked at $583K in Q2 2020.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Clarus Wealth Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.